Investigation of Metabolic Bone Diseases, Metabolic Bone Diseases, Integrative Physiology of the Skeleton
Anthony Norman, Ph.D.
University of California, USA
Hector DeLuca, Ph.D.
University of Wisconsin, Madison, USA
Murray Favus, M.D.
University of Chicago, USA
Lawrence Raisz, M.D.
University of Connecticut Health Center, USA
Roger Bouillon, M.D., Ph.D.
Katholieke Universiteit Leuven, Belgium
Craig Langman, M.D.
Ann & Robert H Lurie Childrens Hospital of Chicago, USA
David Goltzman, M.D.
McGill University, Canada
Supported by educational grants from Eli Lilly and Company, Merck & Co., Inc., NPS Pharmaceuticals, The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis, US) and Immunodiagnostic Systems.
Funding for this conference was made possible (in part) by Grant AR055036 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases and the Office of Dietary Supplements. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Length: 60 minutes